Glycomet GP1 Tablet contains a combination of Glimepiride and Metformin, two powerful anti-diabetic agents used in the management of Type 2 diabetes mellitus.
- Glimepiride: Stimulates insulin release from the pancreas
- Metformin: Reduces glucose production in the liver and improves insulin sensitivity
This dual-action therapy helps achieve better blood sugar control when single drug therapy is not enough.
It is commonly prescribed for:
- Type 2 diabetes mellitus
- High fasting blood sugar
- Post-meal glucose spikes
- Patients not controlled on metformin alone
- Combination therapy for HbA1c reduction
⭐ Key Benefits
- Strong dual-action blood sugar control
- Improves insulin production and sensitivity
- Controls fasting and post-meal sugar
- Helps reduce HbA1c levels
- Effective for long-term diabetes management
⚙️ How It Works
- Glimepiride increases insulin secretion from pancreas
- Metformin reduces liver glucose production
Together they provide balanced and effective glucose control
💊 Usage Instructions
- Take as prescribed by doctor
- Usually taken once or twice daily with meals
- Do not skip doses
- Regular blood sugar monitoring required
⚠️ Safety Information
- Prescription medicine only
- Risk of low blood sugar (hypoglycemia)
- May cause dizziness, nausea, or weight changes
- Avoid alcohol
- Kidney and liver monitoring required
